CCMIC
DTIL icon

Cardinal Capital Management Inc (Canada)’s Precision BioSciences DTIL Stock Holding History

Cardinal Capital Management Inc (Canada)’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-27
Closed -$6K – 93
2021
Q4 		$6K Buy
+27
New +$7.54K ﹤0.01% 75

Other funds holding DTIL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Cardinal Capital Management Inc (Canada)'s DTIL Position: Q1 2022 in Review

Cardinal Capital Management Inc (Canada) sold out of Precision BioSciences (DTIL) in Q1 2022, closing a stake of 27 shares — an estimated $6K sold.

Cardinal Capital Management Inc (Canada) first reported a position in DTIL in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

  • Cardinal Capital Management Inc (Canada) reported no remaining Precision BioSciences position as of Q1 2022 after selling out during the quarter.
  • Cardinal Capital Management Inc (Canada) sold 27 Precision BioSciences shares in Q1 2022, an estimated $6K.
  • Cardinal Capital Management Inc (Canada) first reported a position in Precision BioSciences in Q4 2021 and held it in 1 quarter.
  • Cardinal Capital Management Inc (Canada)'s Precision BioSciences position peaked at $6K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q1 2022, filed 12 Apr 2022.